A therapeutic area moves on data readouts, and most of what circulates about them is publication dressed as reception. WorldbyFlow reads a drug as a dossier, weighs research by who engaged with it rather than who published it, and reads the price and the evidence around it, so your landscape rests on what the field actually responded to.
Written for Runs CI for a therapeutic area at a pharmaceutical company.·Runs in the Health domain
Competitive intelligence for a therapeutic area is a watch on molecules, trials, prices and papers. The scans here are that watch as documents: a medicine dossier, a research pulse that weighs reception, a pricing read with basis and date on every figure, an evidence review on a competitor's asset, and a literature review on the question your franchise depends on.
A drug read as a dossier: approvals, indications, documented trial record, reported commercial performance, what is contested. The competitor asset page, sourced.
Results where someone besides the authors engaged, through citation, replication or follow-on, with disputed findings first-class. What the field is responding to, not what was press-released.
Every price verbatim from a named source with its as-of date and basis stated. The list-versus-net picture, honestly labeled.
The evidence on an intervention read as evidence: what the trials showed, what is contested, what is not yet known. Written for a strategist, never as clinical guidance.
What the literature says on a question your franchise depends on, disagreements included. The reading behind a forecast assumption.
The order matters. The first read gives you the structure; the next ones fill the parts that are hardest to source by hand.
You know this molecule. Check whether the dossier separates the documented trial record from the reported claims the way you would.
What the field is actually engaging with. The gap between this and the press releases is your update.
Basis and date on every figure. The pricing section of the landscape, sourced.
A readout, a label change or a price move becomes a watched signal.
Every figure and quote links to where it came from. A claim the scan could not source is marked as such rather than dressed up.
Export the dossier as a PDF for the franchise review, or share it as a page the brand team can open with every source live.
Ask a follow-up question of any result, or run a Red Team pass that tries to break its own conclusions before someone else does. How the grades work →
Tennessee, Mississippi, North Carolina, and other states are loosening or repealing CON rules as private-equity chains and REIT landlords consolidate hospitals those regulations were designed to oversee.
The fastest way to judge the result is to pick a subject you know cold and read it against what you know. If a colleague sent you here with an invitation, the credits land on your account when you sign up.